ArticleClinical diabetes and endocrinology2016

Cardiovascular safety assessment of pramlintide in type 2 diabetes: results from a pooled analysis of five clinical trials.

Kathrin Herrmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.